company overview
Resilience is a biomanufacturing company that focuses on transforming the production of complex medicines, including advanced biologics, gene therapies, and vaccines. Founded in 2020, the company was created to address the vulnerabilities in global supply chains exposed by the COVID-19 pandemic.
Resilience offers a platform that integrates cutting-edge manufacturing technologies with process development and GMP (Good Manufacturing Practice) infrastructure, enabling the efficient and scalable production of life-saving therapies. The company's business model is designed to support pharmaceutical and biotechnology companies by providing flexible, high-quality manufacturing capabilities, reducing risks, and speeding up the development and delivery of critical medicines.
investment date
August 2020
Industry
Public Health/Life Sciences
headquarters
San Diego, CA